About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

TERMINATEDPhase 1

Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

A Phase 1 Study of MK-1697 in Participants With Advanced Solid Tumors

NCT03515824•Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

NeoplasmsColorectal NeoplasmsHead and Neck Neoplasms

Interventions

MK-1697

Locations

2

Australia

Locations (2)

Scientia Clinical Research ( Site 0100)

Randwick, New South Wales, Australia

Queen Mary Hospital ( Site 0200)

Hong Kong, Hong Kong

Key Dates

Start Date

August 13, 2018

Primary Completion Date

February 18, 2020

Completion Date

February 18, 2020

Last Updated

March 9, 2021

Related Studies

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT00026884

Malignant NeoplasmsHereditary Neoplastic Syndromes+3 more

RECRUITINGPhase 2

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NCT07169851

NauseaVomiting+2 more

RECRUITINGPhase 3

A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

NCT07213804

Ovarian NeoplasmsFallopian Tube Neoplasms+2 more

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

NCT07159659

Thoracic Neoplasms

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

NCT07191730

CardiotoxicityHeart Failure+2 more

RECRUITINGPhase 3

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

NCT06662786

Colorectal Neoplasms

View all related studies

Sponsors

Lead Sponsor

Merck Sharp & Dohme LLC

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions